Document is current
Any future updates will be listed below
-
Authors
Jongkhajornpong, Passara
Lekhanont, Kaevalin https://orcid.org/0000-0003-2292-4581
Rattanasiri, Sasivimol
Pisitkun, Prapaporn
Thakkinstian, Ammarin
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04683796 at ClinicalTrials.govDocuments that mention this clinical trial
Efficacy of 100% autologous platelet-rich plasma and 100% autologous serum in dry eye disease: a randomised controlled trial
https://doi.org/10.1136/bmjophth-2024-001857
Comparison of treatment efficacy between 100% platelet-rich plasma and 100% serum eye drops in moderate-to-severe dry eye disease: a randomised controlled trial protocol (Pre-results)
https://doi.org/10.1136/bmjopen-2020-048479
Comparison of Corneal Epitheliotrophic Factors of Undiluted Autologous Platelet-Rich Plasma and Autologous Serum Eye Drops for Dry Eye Disease
https://doi.org/10.1007/s40123-024-01082-y
-
Funding
Funding for this research was provided by:
Faculty of Medicine Ramathibodi Hospital, Mahidol University (64004)
- License Information
-
More Information
Article History
Received: 16 October 2024
Accepted: 28 November 2024
First Online: 20 December 2024
Declarations
:
: Passara Jongkhajornpong, Kaevalin Lekhanont, Sasivimol Rattanasiri, Prapaporn Pisitkun, and Ammarin Thakkinstian have nothing to disclose.
: The study was approved by the Ethics committee of Ramathibodi Hospital, Mahidol University (No. MURA2022/415) and adhered to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all participants before study enrollment.
